99% Savings - Buy Just @1 Rs X
Triobimet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Diabetes. The alternative uses of Triobimet have also been explained below.
The correct dosage of Triobimet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Triobimet also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Headache. While these are the most often observed Triobimet side effects, there are can be others also. These have been listed below. Such side effects of Triobimet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Triobimet is Unknown for pregnant women and Safe for women who are breastfeeding. Warnings related to Triobimet's effects on the liver, heart and kidney, if any, have been listed below.
Triobimet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Triobimet in conditions like Liver Disease, Kidney Disease.
Drug interactions for Triobimet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Triobimet, it is important to know that it is not safe while driving, and is not habit-forming.
Triobimet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triobimet safe for pregnant women?
The effects of Triobimet on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Triobimet safe during breastfeeding?
Triobimet is completely safe for breastfeeding women.
What is the effect of Triobimet on the Kidneys?
Kidney can be affected by Triobimet. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Triobimet on the Liver?
Triobimet can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Triobimet on the Heart?
Triobimet may have mild side effects on the heart. Most people will never see any effect on the heart.
Triobimet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Triobimet unless your doctor advises you to do so -
Is this Triobimet habit forming or addictive?
No, you will not get addicted to Triobimet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Triobimet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Triobimet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Triobimet is unable to treat or cure mental disorders.
Interaction between Food and Triobimet
Due to a lack of research, nothing can be said about the consequences of taking Triobimet together with food.
Interaction between Alcohol and Triobimet
Information about the interaction of Triobimet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033